Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel.

Autor: Uzoh, C. C.1,2, Holly, J. M. P.1, Biernacka, K. M.1, Persad, R. A.2, Bahl, A.3, Gillatt, D.4, Perks, C. M.1 Claire.m.perks@bristol.ac.uk
Zdroj: British Journal of Cancer. 5/10/2011, Vol. 104 Issue 10, p1587-1593. 7p. 4 Graphs.
Databáze: Academic Search Ultimate